Exposición radiológica de los trabajadores y el público en la primera fase del ensayo clínico del Nimotuzumab marcado con
para el tratamiento de tumores cerebrales en Cuba / Occupational and public exposures in RIT of brain tumors in Cuba
![](http:/img/revistas/nuc/n45/e01014509.jpg)
Nucleus (La Habana)
; (45): 3-10, ene.-jun. 2009. ilus, graf
Article
in Spanish
| LILACS
| ID: lil-738915
Responsible library:
CU1.1
RESUMEN
RESUMEN La primera fase del ensayo clínico del anticuerpo monoclonal humanizado h-R3 (Nimotuzumab) marcado con ABSTRACT
ABSTRACT The first phase of the clinical trial using the humanized monoclonal antibody h-R3 (Nimotuzumab) labelled with ![](http/img/revistas/nuc/n45/e01014509.jpg)
![](http/img/revistas/nuc/n45/e01014509.jpg)
Full text:
Available
Collection:
International databases
Health context:
SDG3 - Target 3.9 Reduce the amount of deaths produced by dangerous chemicals and the pollution of the air, water and soil
Health problem:
Occupational Exposures
Database:
LILACS
Country/Region as subject:
Cuba
Language:
Spanish
Journal:
Nucleus (La Habana)
Journal subject:
Nuclear Medicine
/
Radiotherapy
Year:
2009
Document type:
Article
Affiliation country:
Cuba
Institution/Affiliation country:
Centro de Isótopos (CENTIS)/CU